![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
SurModics to Webcast First Quarter 2014 Earnings Conference Call on January 30
SurModics Inc. a leading provider of surface modification and in vitro diagnostic technologies to the...
RBI seeks clarity on FII investment in pharmaceutical sector
The Reserve Bank of India (RBI) has sought clarity on whether foreign portfolio investments can...
Medtech companies prepare for an innovation makeover
A report by PricewaterhouseCoopers For decades, the medtech industry was on the forefront of innovation,...
Bristol-Myers Squibb reports third quarter 2013 financial results
Bristol-Myers Squibb Company has reported results for the third quarter of 2013 highlighted by the...
Abbott reports third-quarter 2013 results
Abbott today announced financial results for the third quarter ended Sept. 30, 2013. Third-quarter 2013...
Adocia announces its Q1 2013 revenues
Adocia , a biotechnology company specialized in the development of ‘best-in-class’ medicines from already...
Bristol-Myers Squibb reports first quarter 2013 financial results
Bristol-Myers Squibb Company (NYSE: BMY) reported financial results for the first quarter of 2013,...
Abbott reports first-quarter 2013 results
Abbott announced financial results for the first quarter ended March 31, 2013. Worldwide sales...
Bristol-Myers Squibb to Announce Results for First Quarter 2013 on April 25
Bristol-Myers Squibb Company will announce results for the first quarter of 2013 on Thursday...
A strong cash position of EUR 30.5 million, an annual loss of EUR 6.0...
Adocia, a biotechnology company specialized in the development of ‘best-in-class’ medicines from already approved...